Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pediatrics/Neonatology | Dermatology/Plastic Surgery
Disease Category: Eczema (Atopic Dermatitis - Pediatric)
Trial Information
A safety study of a topical cream in pediatric subjects aged 3 years to 5 years 11 month with atopic dermatitis.
Eligibility Criteria:
- Moderate to severe atopic dermatitis involving 35% of body
surface area
- Good general health
- Subjects with Addison's disease, hyperthyroidism, HIV,
diabetes, chronic fatigue syndrome are not allowed
- Patients who might be in need for corticosteroid inhalers or
preparations for other condition not permitted in this study
- Patient with 2 weeks of washout period for corticosteroid use
will be allowed
Hirak B. Routh, MBBS
Paddington Testing Co., Inc
1760 Market Street, Suite 301
Philadelphia, PA 19103
Phone: 215-563-7330
Fax: 215-556-9405
EMail: hirakbrouth@yahoo.com
View Google Map
Research Center Information: Paddington Testing Co., Inc
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
